Delivery Order SPE2DB22D3301-SPE2DB24FY2RB
- Not listed
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corporation's Corporate Office Division. The contract is for the procurement of QUICKVUE AT-HOME COVID-19 TESTS, with a ceiling value of $1,137.55 and a performance period through July 31, 2024. AmerisourceBergen is a major pharmaceutical distributor that holds several Indefinite Delivery Contracts (IDCs) with the DLA and other federal agencies to provide a wide range...
- This federal contract award, valued at $1,418.00, was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order awarded under a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen and the DLA, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for Amerisourcebergen to provide a comprehensive...
- Amerisourcebergen Drug Corp has been awarded a $292 firm fixed price delivery order against an unidentified contract vehicle to supply COVID-19 antigen home test kits to the Defense Logistics Agency. As the prime contractor, Amerisourcebergen Drug Corp will deliver Flowflex COVID-19 antigen home test kits to the DLA by September 14, 2023. The tests will be shipped to the agency's location in Conshohocken, Pennsylvania. Amerisourcebergen Drug Corp is a division of Amerisourcebergen Corporation,...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $10,060.16 delivery order contract is a Firm Fixed Price arrangement with a period of performance through October 29, 2024. Amerisourcebergen holds a larger $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation. The $1,266.60 firm fixed price delivery order is for the provision of various pharmaceutical products and medical supplies, including syringes, vials, test kits, and other critical care materials. This award is associated with a larger indefinite delivery contract (IDC) held by...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $43,443.69 firm fixed-price delivery order, awarded on October 28, 2024 with a completion date of October 29, 2024, is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical. This IDC serves as a primary...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution company. The contract, a firm fixed price delivery order valued at $1,081.35, is for the provision of PFIZER COVID 2023-24(6M-4Y)EUA 0.9ML vaccines and related supplies. The award has a completion date of March 12, 2024 and does not utilize any set-aside...
- This federal contract award was issued by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,427.62 firm-fixed-price delivery order falls under Amerisourcebergen's $999,999,999 Indefinite Delivery Contract (IDC) with the DLA, which runs through November 2026. This IDC serves as the primary vehicle for Amerisourcebergen to supply a comprehensive range of pharmaceutical products and...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $239,774.57 firm fixed-price delivery order contract has a period of performance ending on November 4, 2024. The contract is not designated with a set-aside requirement, indicating open competition. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with...
- This federal contract award was issued by the Medical Supply Chain division of the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $7,767.50 firm fixed-price delivery order contract has an ultimate completion date of November 7, 2024. The contract covers a broad range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and...
- SPE2DB22D3301Indefinite Delivery Contract
- SPE2DB22D3301-SPE2DB24FY2RBDelivery Order
This federal contract award was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a global pharmaceutical distribution company. The $2,278.00 firm fixed price delivery order is for the supply of Quickvue At-Home COVID-19 Tests. The award is part of a larger $999,999,999.00 indefinite delivery contract (IDC) between DLA and Amerisourcebergen Drug Corp, which serves as the primary vehicle for Amerisourcebergen to deliver pharmaceuticals and medical supplies to DLA Troop Support Medical facilities supporting the Department of Defense. This IDC does not fall under any overarching contract vehicles and was awarded solely to Amerisourcebergen Drug Corp. The contract does not have a set-aside designation.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $2.3k | 3/15/24 |